aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
5.51
+0.16 (2.99%)
Jun 6, 2025, 12:11 PM - Market open
aTyr Pharma Market Cap
aTyr Pharma has a market cap or net worth of $490.41 million as of June 6, 2025. Its market cap has increased by 255.37% in one year.
Market Cap
490.41M
Enterprise Value
412.81M
1-Year Change
255.37%
Ranking
Category
Stock Price
5.51
Market Cap Chart
Since May 7, 2015, aTyr Pharma's market cap has increased from $337.10M to $490.41M, an increase of 45.48%. That is a compound annual growth rate of 3.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 457.50M | 50.54% |
| Dec 31, 2024 | 303.90M | 267.92% |
| Dec 29, 2023 | 82.60M | 30.08% |
| Dec 30, 2022 | 63.50M | -69.41% |
| Dec 31, 2021 | 207.60M | 428.24% |
| Dec 31, 2020 | 39.30M | 142.59% |
| Dec 31, 2019 | 16.20M | 8.72% |
| Dec 31, 2018 | 14.90M | -85.70% |
| Dec 29, 2017 | 104.20M | 104.31% |
| Dec 30, 2016 | 51.00M | -78.06% |
| Dec 31, 2015 | 232.50M | -31.03% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.34B |
| Johnson & Johnson | 369.52B |
| AbbVie | 333.74B |
| Novo Nordisk | 315.80B |
| UnitedHealth Group | 273.23B |
| Abbott Laboratories | 232.36B |
| Novartis AG | 226.74B |
| AstraZeneca | 223.00B |